NutraIngredients-Asia Awards 2021

WATCH: Award winner Bened on its psychobiotics business plan in the US and biotherapeutic aspirations

By Tingmin Koe

- Last updated on GMT

Related tags psychobiotics Taiwan stress

Psychobiotics specialist Bened Biomedical will be expanding its business in the US and is also dipping into the pharmaceutical realm by exploring the live biotherapeutic product (LBP) space, the firm’s CEO said.

In the recent NutraIngredients-Asia Awards, the Taiwan-based company took home the Probiotics Product of the Year with its psychobiotics product branded Pure Happiness.  

Containing its proprietary strain Lactobacillus plantarum​ PS128 for supporting relaxation and sleep, the probiotic product has been available in over 20 countries, even countries such as Africa.

CEO Frankie Cheng told NutraIngredients-Asia ​that over one million boxes of Pure Happiness have been sold in the past four to five years.

“The key consumer groups are made of sub-healthy population that experience insomnia, high stress, anxiety, or depression,” ​he said, adding that awareness of psychobiotics has increased due to the growing scientific evidence. 

To date, eight human clinical studies have been published on PS128 and its other probiotic strain Lactobacillus paracasei ​PS23 – which has been shown to reverse behaviours associated with anxiety and depression.

Asked the upcoming plans, Cheng said the company has been planning for a “more aggressive expansion” ​next year in the US, with a focus on the D2C model.

“We just completed a very successful series A fundraising and are poised to take on many more countries and channels to further increase market penetration.

“We are so psyched about our ever more aggressive expansion in 2022, especially in the United States. Indeed, we are planning to roll out our products based on the D2C model in the States,” ​he said.

In addition, he revealed that the company would be exploring the pharmaceutical space.

“We already started the work to turn our psychobiotics into a pharmaceutical LBP and have applied for investigational new drug development from the FDA.

“We firmly believe that with FDA’s new drug approval, we can potentially become the first-in-class psychobiotics therapeutic provider in the world.”

Watch the video to find out more.

Related news

Show more

Related products

show more

Krill oil supports six key areas of healthy aging

Krill oil supports six key areas of healthy aging

Content provided by Aker BioMarine | 26-Feb-2024 | White Paper

The global population is getting older—according to WHO by 2050 the world’s population over 60 years will double and the population above 80 years will...

Nootropics Report 2.0: Brain Health Insights

Nootropics Report 2.0: Brain Health Insights

Content provided by dsm-firmenich | 22-Feb-2024 | Insight Guide

The brain health market is constantly growing and evolving, with more consumers looking for innovative ways to support total mind and body wellness.

Revolutionizing Brain Health with BioKesum®

Revolutionizing Brain Health with BioKesum®

Content provided by Biotropics Malaysia | 20-Feb-2024 | Data Sheet

Revitalize the nootropic industry with new clinically proven herbal extract from Kesum leaves shown to improve executive memory, mood and brain markers...

Pycnogenol® Supports Cognitive Function at Any Age

Pycnogenol® Supports Cognitive Function at Any Age

Content provided by Horphag Research | 07-Feb-2024 | White Paper

Clinical research shows daily supplementation with Pycnogenol® French maritime pine bark extract may help support brain function in a variety of age groups...

Follow us


View more


Nutra Champions Podcast

Nutra Champions Podcast